Setsuko Kuki Chambers, MD
Setsuko Kuki Chambers, MD
Director of Women's Cancers
University of Arizona Cancer Center
1515 N. Campbell Ave.
PO Box 245024
Tucson,
AZ
USA
85724-5024
Papers:
8
A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)